Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site
RALEIGH, N.C., May 22, 2013 /PRNewswire/ — STEPh, Inc., a full service medical communications company, is pleased to announce the launch of their web site ( http://www.stephreports.com ) dedicated to investigational drug reports [STEPh Reports].
About STEPh Reports
STEPh Reports are comprehensive critical reviews of drugs in development.
Each STEPh Report assesses the competitive landscape by individual drug monograph, MOA, clinical trials data, projected launch year, company, and specific key issues. STEPh Reports are written by individuals with expertise in clinical pharmacology and knowledge of drug development processes. Reports are reviewed by subject matter experts. STEPh Reports are updated quarterly and are fully referenced, including links to original source documents. Complementary features to STEPh Reports include daily and archival news services, pipeline tables, mini reviews of Hot Topics, and links to key resources. A Q&A service is also available upon request.
STEPh Reports are available for purchase by yearly subscription to the web site. The service is available also to individuals and sponsors at a nominal charge.
Other Services Offered by STEPh, Inc.
Medical Writing–manuscripts, abstracts, posters, product monographs, training materials. STEPh, Inc., has an impeccable track record for manuscript acceptance in peer review journals, and has developed Product Monographs and learning systems to support new product launches.
Medical Information–creation of standard response letters, support for product launches. The President of STEPh, Inc., Dr. Bauman, is a founding member of the Medical Communications subgroup of DIA and has been a Medical Information practitioner for over 30 years. He supervised the medical information support for numerous new product launches and coordinated international medical information services.
Competitive Intelligence (CI)–investigational drug reports, individualized primary research, meetings coverage. The principals at STEPh, Inc., are notable leaders in CI and have practiced this discipline for more than 20 years.
About STEPh, Inc.
STEPh, Inc., was formed in 2005 by pharmaceutical industry veterans, each with more than 20 years’ experience in Medical Affairs departments of large pharma and biotech companies. Dr. Jay Bauman is former Editor of Hospital Edition of US Pharmacist, invited speaker at SCIP meetings, and accomplished author with more than 30 technical publications.
Further information about pricing for services can be obtained by contacting STEPh, Inc., as noted below:
Dr. Jay H. Bauman
President, STEPh, Inc.
SOURCE Scientific and Technical Evaluation of Pharmaceuticals, Inc.